Delta 9 Develops Proprietary Decontamination Technology to Help Fight COVID-19 Pandemic

▴ Delta 9 Develops Proprietary Decontamination Technology to Help Fight COVID-19 Pandemic
DELTA 9 CANNABIS INC is pleased to announce that it has developed and validated new proprietary decontamination Technology, which helps to fight COVID-19 Pandemic.

DELTA 9 CANNABIS INC is pleased to announce that it has developed and validated new proprietary decontamination equipment, branded the “Decontamination Pod” (or “D-Pod”), which can be used to decontaminate medical supplies, personal protective equipment (“PPE”), and other equipment.

Canadian and US patent applications have been filed on behalf of the Company for the D-Pod, which is a standard shipping container retrofitted to include heating and ultraviolet light technologies. When PPE or other materials are placed inside the treatment area of the D-Pod, the combination of heat and UVC is sufficient to kill the COVID-19 virus.

“This technology could be a game-changer for governments, hospitals, and care facilities in the fight against COVID-19, allowing them to decontaminate large amounts of PPE and other equipment, increasing the availability of existing PPE inventories and preventing potential exposures to the virus,” said John Arbuthnot, CEO of Delta 9. “We are extremely proud of our employees and partners for bringing this technology to this point and look forward to continuing to do our part in providing solutions to this health crisis.”

The Company, through a newly incorporated and partially owned subsidiary, Blue Horseshoe Manufacturing Inc., plans to manufacture and distribute the new technology across North America, providing a new tool for governments, health care facilities, long-term care facilities, businesses, and First Nations in their fight against COVID-19.

The Company will leverage the success of its cannabis grow pod division which has produced and installed over 500 pods for in-house and third-party facilities since 2017 and use its existing cannabis grow pod manufacturing facilities in Winnipeg to manufacture the first D-Pods.

Management believes that the Company will quickly be able to ramp up production capacity to 16 to 20 D-Pods per month while working with other Canadian manufacturers to compliment its internal capacity. The D-Pods are expected to sell for approximately $250,000 per unit. The Company has already received inquiries from groups interested in deploying the technology and expects to begin taking orders in the coming week.

The technology used in the D-Pods was originally developed in partnership between Delta 9, RSR Project Management Ltd., Northern Green Homes Inc., and Connco Electric and the finished D-Pod was tested and validated by an independent and accredited third party lab, BioScision Pharma Inc., which confirmed that the technology should be effective in decontaminating materials which may be contaminated with the COVID-19 virus.

The D-Pod is the first innovation of Delta 9’s grows pod business unit which can be used as a tool in the fight against COVID-19. The Company is now developing additional technologies that can decontaminate equipment at low temperatures and modular storage and transport units that can be used to store and distribute vaccines while maintaining quality and stability.

Tags : #Delta9Cannabis #DecontaminationPod #DecontaminationTechnology #FightAgainstCovid19 #Covid19 #BlueHorseshoe #D-Pod #CoronaVirus

About the Author


Rohit Sharma

Writer, Health Enthusiast, and an Accountant, Rohit Sharma is a writer at medicircle, penning down his thoughts about healthcare research, innovations, trends in healthcare and simply all about healthcare. Write to rohit on [email protected]

Related Stories

Loading Please wait...
-Advertisements-


Trending Now

“Early Detection of Rheumatoid Arthritis Can Help” by Dr.Rohit Chakor, Rheumatologist Specialist & Consultant Orthopedic Surgeon March 09, 2021
“Technology adds value to healthcare,” says Dr.Naresh Yallapragada, Chief Information Officer at Krishna Institute of Medical SciencesMarch 09, 2021
Behavioral Changes Towards Innovation in Technology is the Need of the Hour, says Bitopan Sarma Baruah, Head IT and Business Process, Excelcare HospitalsMarch 08, 2021
Keep It Simple, Keep it Local, says Kavita Bhatia, Clinical DietitianMarch 06, 2021
6 Top Women Entrepreneurs and CXOs are Transforming Healthcare for the BetterMarch 06, 2021
Top 4 reasons to visit a dentist today March 06, 2021
“Reframe your thoughts to prevent Dissociative Identity Disorder (DID)” by Dr.Sheereen K Bajpai, Expert Psychologist & Counselor from Indian Institute of Science Education and ResearchMarch 06, 2021
Digitalization Should Enable Clinicians to Focus on The Human Touch, says Dr. George Fernandes, CEO, Viveka HospitalsMarch 05, 2021
March 5 th 2021- Dissociative Identity Disorder(DID) Awareness DayMarch 04, 2021
Are You Struggling with “Maskne”? Find the Top 5 Solutions to deal with it. March 03, 2021
Exercise could well mimic the effects of Polypill , also it's cheaper and without side effectsMarch 03, 2021
Sorrento receives USFDA clearance to start a clinical trial of Anti-CD47 antibodyMarch 03, 2021
Regular breast checks by trained health workers linked to fewer breast cancer deaths in IndiaMarch 03, 2021
Treat Doctors as Friends and Have an Open Chat with Them says Dr. Shailaja Sabnis, Consultant Physician and Rheumatologist March 03, 2021
PM Jan Aushadhi Kendra inaugurated at District Hospital, KargilMarch 02, 2021
Maharashtra records 6,397 new cases of coronavirus todayMarch 02, 2021
One in four people will have hearing problems by 2050: WHOMarch 02, 2021
6 states show surge in Covid-19 cases, India's total active cases reach 1,68,627March 02, 2021
hday for longer life ; American Heart AssociationMarch 02, 2021
Is your baby cranky due to skin complaints? Here are some quick solutions that can help you.March 02, 2021